Adaptive Biotechnologies Corporation (ADPT) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Carina Calzadilla, Head of Investor Relations. Please go ahead. Thank you, Tonya, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies Second Quarter twenty twenty six Earnings Conference Call. Earlier today, we issued a press release reporting Adaptive financial results for the second quarter. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of this call and will be referencing to the slide presentation that has been posted in the Investors section in our corporate website. During the call, management will make projections and other forward looking statements within the meaning of federal security laws regarding future events and the future financial performance of the company. These statements reflect management's current perspective of the business as of today. Actual results may differ materially from today's forward looking statements depending on a number of factors, which are set forth in our public filings with the SEC and listed in this presentation. In addition, non GAAP financial measures will be discussed during the call and a reconciliation from non GAAP to GAAP metrics can be found in our earnings release. Joining the call today are Chad Rollins, our CEO and Co Founder and Kyle Fischl, our Chief Financial Officer. Additional members from management will be available for Q and A. With that, I'll turn...